ÌÇÐÄvlog

Object moved to here.

Age-Related Risk of Serious Fall Events and Opioid Analgesic Use | Orthopedics | JAMA Internal Medicine | ÌÇÐÄvlog

ÌÇÐÄvlog

[Skip to Navigation]
Sign In
1.
Australian Institute of Health and Welfare. ÌýTrends in Hospitalised Injury, Australia 2007-08 to 2016-17. AIHW; 2019.
2.
Australian Institute of Health and Welfare. ÌýTrends in Injury Deaths, Australia, 1999-00 to 2016-17. AIHW; 2019.
3.
Australian Institute of Health and Welfare. Ìý±õ²ÔÂá³Ü°ù²â in Australia. AIHW; 2022.
4.
Verma ÌýSK, Willetts ÌýJL, Corns ÌýHL, Marucci-Wellman ÌýHR, Lombardi ÌýDA, Courtney ÌýTK. ÌýFalls and fall-related injuries among community-dwelling adults in the United States.Ìý ÌýPLoS One. 2016;11(3):e0150939. doi:
5.
James ÌýMK, Victor ÌýMC, Saghir ÌýSM, Gentile ÌýPA. ÌýCharacterization of fall patients: does age matter?Ìý ÌýJ Safety Res. 2018;64:83-92. doi:
6.
Australian Institute of Health and Welfare. ÌýTrends in Hospitalised Injury Due to Falls in Older People 2007-08 to 2016-17. AIHW; 2019.
7.
Harvey ÌýLA, Close ÌýJCT. ÌýTraumatic brain injury in older adults: characteristics, causes and consequences.Ìý Ìý±õ²ÔÂá³Ü°ù²â. 2012;43(11):1821-1826. doi:
8.
Benyamin ÌýR, Trescot ÌýAM, Datta ÌýS, Ìýet al. ÌýOpioid complications and side effects.Ìý ÌýPain Physician. 2008;11(2)(suppl):S105-S120. doi:
9.
Dhingra ÌýL, Ahmed ÌýE, Shin ÌýJ, Scharaga ÌýE, Magun ÌýM. ÌýCognitive effects and sedation.Ìý ÌýPain Med. 2015;16(suppl 1):S37-S43. doi:
10.
Degenhardt ÌýL, Gisev ÌýN, Cama ÌýE, Nielsen ÌýS, Larance ÌýB, Bruno ÌýR. ÌýThe extent and correlates of community-based pharmaceutical opioid utilisation in Australia.Ìý ÌýPharmacoepidemiol Drug Saf. 2016;25(5):521-538. doi:
11.
Gisev ÌýN, Pearson ÌýSA, Blanch ÌýB, Ìýet al. ÌýInitiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated.Ìý ÌýBr J Clin Pharmacol. 2016;82(4):1123-1133. doi:
12.
Hollingworth ÌýSA, Gray ÌýPD, Hall ÌýWD, Najman ÌýJM. ÌýOpioid analgesic prescribing in Australia: a focus on gender and age.Ìý ÌýPharmacoepidemiol Drug Saf. 2015;24(6):628-636. doi:
13.
Roxburgh ÌýA, Bruno ÌýR, Larance ÌýB, Burns ÌýL. ÌýPrescription of opioid analgesics and related harms in Australia.Ìý ÌýMed J Aust. 2011;195(5):280-284. doi:
14.
Blyth ÌýFM, Cumming ÌýR, Mitchell ÌýP, Wang ÌýJJ. ÌýPain and falls in older people.Ìý ÌýEur J Pain. 2007;11(5):564-571. doi:
15.
Deandrea ÌýS, Bravi ÌýF, Turati ÌýF, Lucenteforte ÌýE, La Vecchia ÌýC, Negri ÌýE. ÌýRisk factors for falls in older people in nursing homes and hospitals: a systematic review and meta-analysis.Ìý ÌýArch Gerontol Geriatr. 2013;56(3):407-415. doi:
16.
Deandrea ÌýS, Lucenteforte ÌýE, Bravi ÌýF, Foschi ÌýR, La Vecchia ÌýC, Negri ÌýE. ÌýRisk factors for falls in community-dwelling older people: a systematic review and meta-analysis.Ìý Ìý·¡±è¾±»å±ð³¾¾±´Ç±ô´Ç²µ²â. 2010;21(5):658-668. doi:
17.
Leveille ÌýSG, Jones ÌýRN, Kiely ÌýDK, Ìýet al. ÌýChronic musculoskeletal pain and the occurrence of falls in an older population.Ìý Ìý´³´¡²Ñ´¡. 2009;302(20):2214-2221. doi:
18.
Page ÌýAT, Falster ÌýMO, Litchfield ÌýM, Pearson ÌýSA, Etherton-Beer ÌýC. ÌýPolypharmacy among older Australians, 2006-2017: a population-based study.Ìý ÌýMed J Aust. 2019;211(2):71-75. doi:
19.
Stubbs ÌýB, Binnekade ÌýT, Eggermont ÌýL, Sepehry ÌýAA, Patchay ÌýS, Schofield ÌýP. ÌýPain and the risk for falls in community-dwelling older adults: systematic review and meta-analysis.Ìý ÌýArch Phys Med Rehabil. 2014;95(1):175-187.e9. doi:
20.
Bloch ÌýF, Thibaud ÌýM, Dugué ÌýB, Brèque ÌýC, Rigaud ÌýAS, Kemoun ÌýG. ÌýPsychotropic drugs and falls in the elderly people: updated literature review and meta-analysis.Ìý ÌýJ Aging Health. 2011;23(2):329-346. doi:
21.
Seppala ÌýLJ, van de Glind ÌýEMM, Daams ÌýJG, Ìýet al; EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs. ÌýFall-risk–increasing drugs: a systematic review and meta-analysis: III. Others.Ìý ÌýJ Am Med Dir Assoc. 2018;19(4):372.e1-372.e8. doi:
22.
Yoshikawa ÌýA, Ramirez ÌýG, Smith ÌýML, Ìýet al. ÌýOpioid use and the risk of falls, fall injuries and fractures among older adults: a systematic review and meta-analysis.Ìý ÌýJ Gerontol A Biol Sci Med Sci. 2020;75(10):1989-1995. doi:
23.
Modén ÌýB, Merlo ÌýJ, Ohlsson ÌýH, Rosvall ÌýM. ÌýPsychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden.Ìý ÌýJ Epidemiol Community Health. 2010;64(5):440-446. doi:
24.
Söderberg ÌýKC, Laflamme ÌýL, Möller ÌýJ. ÌýNewly initiated opioid treatment and the risk of fall-related injuries: a nationwide, register-based, case-crossover study in Sweden.Ìý ÌýCNS Drugs. 2013;27(2):155-161. doi:
25.
Close ÌýJCT, Hooper ÌýR, Glucksman ÌýE, Jackson ÌýSHD, Swift ÌýCG. ÌýPredictors of falls in a high risk population: results from the prevention of falls in the elderly trial (PROFET).Ìý ÌýEmerg Med J. 2003;20(5):421-425. doi:
26.
Gisev ÌýN, Pearson ÌýSA, Dobbins ÌýT, Ìýet al. ÌýCohort profile: POPPY II—a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia.Ìý Ìýµþ²Ñ´³ Open. 2023;13(5):e068310. doi:
27.
Gisev ÌýN, Pearson ÌýSA, Dobbins ÌýT, Ìýet al. ÌýCombating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol.Ìý Ìýµþ²Ñ´³ Open. 2018;8(12):e025840. doi:
28.
Langan ÌýSM, Schmidt ÌýSA, Wing ÌýK, Ìýet al. ÌýThe reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).Ìý Ìýµþ²Ñ´³. 2018;363:k3532. doi:
29.
Lalic ÌýS, Ilomäki ÌýJ, Bell ÌýJS, Korhonen ÌýMJ, Gisev ÌýN. ÌýPrevalence and incidence of prescription opioid analgesic use in Australia.Ìý ÌýBr J Clin Pharmacol. 2019;85(1):202-215. doi:
30.
Australian Bureau of Statistics. 3101.0—Australian Demographic Statistics, Jun 2018. Accessed August 2, 2023.
31.
Pharmaceutical Benefits Scheme. About the PBS. Accessed April 29, 2023.
32.
Gisev ÌýN, Pearson ÌýSA, Karanges ÌýEA, Ìýet al. ÌýTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Ìý ÌýPharmacoepidemiol Drug Saf. 2018;27(5):550-555. doi:
33.
Bharat ÌýC, Degenhardt ÌýL, Pearson ÌýSA, Ìýet al. ÌýA data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data.Ìý ÌýPharmacoepidemiol Drug Saf. 2023;32(3):352-365. doi:
34.
Manchikanti ÌýL, Kaye ÌýAM, Knezevic ÌýNN, Ìýet al. ÌýResponsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines.Ìý ÌýPain Physician. 2017;20(2S):S3-S92. doi:
35.
Australian Bureau of Statistics. 1270.0.55.005—Australian Statistical Geography Standard (ASGS): volume —remoteness structure, 2016. Accessed Jan 29, 2021.
36.
Pink ÌýB. Socio-economic indexes for areas (SEIFA) 2011. Accessed August 2, 2023.
37.
Fastbom ÌýJ, Schmidt ÌýI. ÌýIndikatorer för God Läkemedelsterapi Hos Äldre. The Swedish National Board of Health and Welfare; 2010.
38.
de Vries ÌýM, Seppala ÌýLJ, Daams ÌýJG, van de Glind ÌýEMM, Masud ÌýT, van der Velde ÌýN; EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs. ÌýFall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs.Ìý ÌýJ Am Med Dir Assoc. 2018;19(4):371.e1-371.e9. doi:
39.
Seppala ÌýLJ, Wermelink ÌýAMAT, de Vries ÌýM, Ìýet al; EUGMS task and Finish group on fall-risk-increasing drugs. ÌýFall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics.Ìý ÌýJ Am Med Dir Assoc. 2018;19(4):371.e11-371.e17. doi:
40.
Gilbert ÌýT, Neuburger ÌýJ, Kraindler ÌýJ, Ìýet al. ÌýDevelopment and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study.Ìý Ìý³¢²¹²Ô³¦±ð³Ù. 2018;391(10132):1775-1782. doi:
41.
Street ÌýA, Maynou ÌýL, Gilbert ÌýT, Stone ÌýT, Mason ÌýS, Conroy ÌýS. ÌýThe use of linked routine data to optimise calculation of the Hospital Frailty Risk score on the basis of previous hospital admissions: a retrospective observational cohort study.Ìý Ìý³¢²¹²Ô³¦±ð³Ù Healthy Longev. 2021;2(3):e154-e162. doi:
42.
VanderWeele ÌýTJ, Ding ÌýP. ÌýSensitivity analysis in observational research: introducing the E-Value.Ìý ÌýAnn Intern Med. 2017;167(4):268-274. doi:
43.
Court-Brown ÌýCM, Clement ÌýND, Duckworth ÌýAD, Biant ÌýLC, McQueen ÌýMM. ÌýThe changing epidemiology of fall-related fractures in adults.Ìý Ìý±õ²ÔÂá³Ü°ù²â. 2017;48(4):819-824. doi:
44.
Ensrud ÌýKE. Ìý·¡±è¾±»å±ð³¾¾±´Ç±ô´Ç²µ²â of fracture risk with advancing age.Ìý ÌýJ Gerontol A Biol Sci Med Sci. 2013;68(10):1236-1242. doi:
45.
Vieira ÌýER, Palmer ÌýRC, Chaves ÌýPHM. ÌýPrevention of falls in older people living in the community.Ìý Ìýµþ²Ñ´³. 2016;353:i1419. doi:
46.
de Jong ÌýMR, Van der Elst ÌýM, Hartholt ÌýKA. ÌýDrug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies.Ìý ÌýTher Adv Drug Saf. 2013;4(4):147-154. doi:
47.
Karlsson ÌýMK, Magnusson ÌýH, von Schewelov ÌýT, Rosengren ÌýBE. ÌýPrevention of falls in the elderly–a review.Ìý ÌýOsteoporos Int. 2013;24(3):747-762. doi:
48.
Hopewell ÌýS, Adedire ÌýO, Copsey ÌýBJ, Ìýet al. ÌýMultifactorial and multiple component interventions for preventing falls in older people living in the community.Ìý ÌýCochrane Database Syst Rev. 2018;7(7):CD012221. doi:
49.
Guirguis-Blake ÌýJM, Michael ÌýYL, Perdue ÌýLA, Coppola ÌýEL, Beil ÌýTL. ÌýInterventions to prevent falls in older adults: updated evidence report and systematic review for the US Preventive Services Task Force.Ìý Ìý´³´¡²Ñ´¡. 2018;319(16):1705-1716. doi:
50.
Karttunen ÌýN, Lihavainen ÌýK, Sipilä ÌýS, Rantanen ÌýT, Sulkava ÌýR, Hartikainen ÌýS. ÌýMusculoskeletal pain and use of analgesics in relation to mobility limitation among community-dwelling persons aged 75 years and older.Ìý ÌýEur J Pain. 2012;16(1):140-149. doi:
51.
Cheng ÌýS, Siddiqui ÌýTG, Gossop ÌýM, Stavem ÌýK, Kristoffersen ÌýES, Lundqvist ÌýC. ÌýHealth-related quality of life in hospitalized older patients with versus without prolonged use of opioid analgesics, benzodiazepines, and z-hypnotics: a cross-sectional study.Ìý ÌýBMC Geriatr. 2020;20(1):425. doi:
52.
Freiberger ÌýE, Sieber ÌýCC, Kob ÌýR. ÌýMobility in older community-dwelling persons: a narrative review.Ìý ÌýFront Physiol. 2020;11:881. doi:
53.
Talbot ÌýLA, Musiol ÌýRJ, Witham ÌýEK, Metter ÌýEJ. ÌýFalls in young, middle-aged and older community dwelling adults: perceived cause, environmental factors and injury.Ìý ÌýBMC Public Health. 2005;5(1):86. doi:
Views 4,865
Original Investigation
February 19, 2024

Age-Related Risk of Serious Fall Events and Opioid Analgesic Use

Author Affiliations
  • 1National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia
  • 2Neuroscience Research Australia, UNSW Sydney, Sydney, New South Wales, Australia
  • 3School of Population Health, UNSW Sydney, Sydney, New South Wales, Australia
  • 4School of Clinical Medicine, Discipline of Psychiatry and Mental Health, UNSW Sydney, Sydney, New South Wales, Australia
  • 5Menzies Centre for Health Policy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
JAMA Intern Med. 2024;184(4):394-401. doi:10.1001/jamainternmed.2023.8154
Key Points

QuestionÌý What is the association between age-related risk of serious fall events and opioid analgesic use?

FindingsÌý In this population-based cohort study of 3.2 million people who initiated prescription opioid treatment, opioid exposure was associated with increased risk of serious fall events among adults of all ages. Risk significantly increased with age and within the first 28 days of commencing opioid use.

MeaningÌý The results of this study suggest that fall risk should be considered when prescribing opioids in adults, particularly in the first 4 weeks of treatment, and among individuals with preexisting risk factors for falls, including older age.

Abstract

ImportanceÌý Opioid analgesics may be associated with increased risk of falls, particularly among older adults.

ObjectiveÌý To quantify the age-related risk of serious fall events among adults prescribed opioids by opioid exposure, time from initiation, and daily dose.

Design, Setting, and ParticipantsÌý This population-based cohort study conducted in New South Wales, Australia, used data linking national pharmaceutical claims to national and state datasets, including information on sociodemographic characteristics, clinical characteristics, medicines use, health services utilization, and mortality (POPPY II study). It included adults (18 years or older) who initiated prescription opioid treatment, which was defined as no prior dispensing during the preceding 365 days, between January 1, 2005, and December 31, 2018. Data were analyzed from February to June 2023.

ExposureÌý Time-dependent periods of opioid exposure were evaluated from dispensing records.

Main Outcome and MeasuresÌý Serious fall events identified from emergency department, hospitalization, and mortality records. Negative binomial models were used to assess associations between time-dependent opioid exposure (overall, by time from initiation, and by dose), age, and risk of fall events. Models were adjusted for known fall risk factors, including other fall risk–increasing drugs, frailty risk, and prior serious fall events.

ResultsÌý The cohort comprised 3 212 369 individuals who initiated prescription opioid treatment (1 702 332 women [53%]; median [IQR] age at initiation, 49 [32-65] years). Overall, 506 573 serious fall events were identified, including 5210 fatal falls. During exposure to opioids, the risk of serious fall events was elevated among all age groups; compared with the group aged 18 to 44 years, this risk was highest among those 85 years or older (adjusted incident rate ratio, 6.35; 95% CI, 6.20-6.51). Across all age groups, the first 28 days following opioid initiation was a time of increased serious fall risk; this risk increased with age. Among individuals aged 18 to 84 years, associations were identified between higher daily opioid doses and serious fall events.

Conclusions and RelevanceÌý The results of this cohort study suggest that prescription opioids were associated with increased risk of serious fall events among adults of all ages, with individuals 85 years or older at greatest risk. These risks should be considered when prescribing opioids, particularly for individuals with preexisting risk factors or when opioids are prescribed at higher doses. Targeted falls prevention efforts may be most effective within the first month following opioid initiation.

×